Top

Published in:

01-08-2020 | Acute Respiratory Distress-Syndrome | CE - COMMENTARY

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine

Authors: Riccardo Polosa, Grazia Caci

Published in: Internal and Emergency Medicine | Issue 5/2020

Excerpt

All the world is aware of the Coronavirus pandemic, and as of the 23rd of April 2020 globally 2.629.801 cases had been confirmed, and 183.454 fatalities had occurred (https://coronavirus.jhu.edu/map.html). The world is struggling and working to contain the disease and death of this active new virus. On top of the medical toll, the COVID-19 pandemic has resulted in severe economic devastation that has tragic and widespread consequences for human health and suffering. …

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, China Medical Treatment Expert Group for Covid-19 et al (2020) Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020(Epub ahead of print)CrossRefPubMedPubMedCentral

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3(Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038)CrossRefPubMedPubMedCentral

Zhao X, Zhang B, Li P et al (2020) Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv. https://doi.org/10.1101/2020.03.17.20037572CrossRefPubMedPubMedCentral

Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, Wang Q, Miao H (2020) Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 27(5):33. https://doi.org/10.1038/s41392-020-0148-4CrossRef

Rodríguez LA, Ruigómez A, Wallander MA, Johansson S (2009) Acid-suppressive drugs and community-acquired pneumonia. Epidemiology 20:800–806. https://doi.org/10.1097/EDE.0b013e3181b5f27dCrossRefPubMed

Almirall J, Blanquer J, Bello S (2014) Community-acquired pneumonia among smokers. Arch Bronconeumol 50:250–254. https://doi.org/10.1016/j.arbres.2013.11.016CrossRefPubMed

Feldman C, Anderson R (2013) Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect 67(3):169–184CrossRefPubMed

Cai H (2020) Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 8(4):e20. https://doi.org/10.1016/S2213-2600(20)30117-X(Epub 2020 Mar 11. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26)CrossRefPubMedPubMedCentral

Farsalinos KF, Barbouni A, Niaura R (2020) Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. https://doi.org/10.1007/s11739-020-02355-7CrossRefPubMedPubMedCentral

10.

Chow N, Fleming-Dutra K, Gierke R, Hall A (2020) Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 69:382–386. https://doi.org/10.15585/mmwr.mm6913e2CrossRefPubMedCentral

11.

Creamer MR, Wang TW, Babb S et al (2019) tobacco product use and cessation indicators among adults—United States, 2018. MMWR Morb Mortal Wkly Rep 68:1013–1019. https://doi.org/10.15585/mmwr.mm6845a2CrossRefPubMedPubMedCentral

12.

Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell LF, Chernyak Y, Tobin K, Cerfolio RJ, Francois F, Horwitz LI (2020) Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City. medRxiv. https://doi.org/10.1101/2020.04.08.20057794CrossRef

13.

https://www.medrxiv.org/content/10.1101/2020.04.08.20057794v1. Accessed 23 Apr 2020

14.

Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, Daher A, Stöhr R, Kleines M, Lemmen SW, Brokmann JC, Müller T, Müller-Wieland D, Marx G, Marx N (2020) Charakteristik von 50 hospitalisierten COVID-19-patienten mit und ohne ARDS. Dtsch Arztebl Int 117:271–278. https://doi.org/10.3238/arztebl.2020.0271CrossRefPubMedPubMedCentral

15.

Miyara M, Tubach F, Pourcher V et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19. https://www.qeios.com/read/article/569. Accessed 23 Apr 2020

16.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032(Epub ahead of print)CrossRefPubMedPubMedCentral

17.

Tang X, Du R, Wang R, Cao T, Guan L, Yang C, Zhu Q, Hu M, Li X, Li Y, Liang L, Tong Z, Sun B, Peng P, Shi H (2020) Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1. Chest. https://doi.org/10.1016/j.chest.2020.03.032(Epub ahead of print)CrossRefPubMed

18.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD (2020) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy. https://doi.org/10.1111/all.14238CrossRefPubMed

19.

Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2(5):372–377CrossRefPubMed

20.

Fagone P, Mazzon E, Bramanti P, Bendtzen K, Nicoletti F (2018) Gasotransmitters and the immune system: mode of action and novel therapeutic targets. Eur J Pharmacol 5(834):92–102. https://doi.org/10.1016/j.ejphar.2018.07.026CrossRef

21.

Bastaki SM, Adeghate E, Amir N, Ojha S, Oz M (2018) Menthol inhibits oxidative stress and inflammation in acetic acid-induced colitis in rat colonic mucosa. Am J Transl Res 10(12):4210–4222PubMedPubMedCentral

22.

Hajiasgharzadeh K, Sadigh-Eteghad S, Mansoori B, Mokhtarzadeh A, Shanehbandi D, Doustvandi MA, Asadzadeh Z, Baradaran B (2019) Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: friends or foes? J Cell Physiol. https://doi.org/10.1002/jcp.28220CrossRefPubMed

23.

Greenland S, Satterfield M, Lanes S (1998) A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf 18:297–308CrossRefPubMed

24.

McNeill A, Brose LS, Calder R, Bauld L, Robson D (2020) Vaping in England: an evidence update including mental health and pregnancy, March 2020: a report commissioned by Public Health England. Public Health England, London

25.

McNeill A, Brose LS, Calder R, Bauld L, Robson D (2018) Evidence review of e-cigarettes and heated tobacco products, 2018. A Report Commissioned by Public Health England. Public Health England, London

Title: COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
Authors: Riccardo Polosa
Grazia Caci
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Acute Respiratory Distress-Syndrome
COVID-19
Published in: Internal and Emergency Medicine / Issue 5/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02361-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2020

When internal and emergency medicine speak to each other: organization in the time of COVID

Triage decision-making at the time of COVID-19 infection: the Piacenza strategy

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage